TOP STORIES

• REGULATORY Choseido Hit by Biz Suspension of Up to 31 Days over Manufacturing Flaws
  October 11, 2021

• REGULATORY Japan Clinches Deal for 120 Million Extra Pfizer Vaccine Doses
  October 8, 2021

• BUSINESS Licensing Izcargo to Takeda First Step to Expanded Application of JCR’s BBB-Penetrating Technology: Chairman
  October 8, 2021

• ORGANIZATION JMA Exec Chides Pharma for Requesting Price Measure to Ensure Stable Supplies, Says Compliance System Should Come First
  October 7, 2021

• BUSINESS Takeda Suspends PII Trials of Narcolepsy Drug Hopeful on Safety Concerns
  October 7, 2021

• BUSINESS Oncolys Aims to Bring Nucleocapsid Inhibitor into Clinic Next Year for COVID-19 Treatment
  October 6, 2021

• REGULATORY Transparency and Predictability Up for Discussion towards 2022 Drug Pricing Reform: New Minister
  October 6, 2021

• REGULATORY New Health Minister Goto Vows to Protect Secure Healthcare System in FY2022 Reform
  October 5, 2021

• REGULATORY No Factor to Impede Reinstatement of HPV Vaccine Recommendation: Panels
  October 4, 2021

• ORGANIZATION FPMAJ to Define Shipment Situation in Preparation for Supply Information Centralization
  October 1, 2021

• BUSINESS Sumitomo Dainippon, Otsuka Ink Global Collaboration for 4 Neuropsychiatric Drugs
  October 1, 2021

• REGULATORY Pharma Officials Air Hopes and Concerns for New LDP Leader, Eyes on MHLW Revamp
  September 30, 2021

• ORGANIZATION FPMAJ Chief Praises Political Acumen of New LDP Leader Kishida, Seeks Support for Industry
  September 30, 2021

• COMMENTARY 5 Companies Developing Japan-Made COVID-19 Jabs Face Challenges in Subject Enrollment, Trial Designs
  September 29, 2021

• BUSINESS Shionogi Kicks Off Japan PII/III Trial for Oral COVID-19 Drug
  September 29, 2021

• REGULATORY Japan Approves Padcev, Entresto’s Hypertension Use, Lilly’s RET Inhibitor and More
  September 28, 2021

• REGULATORY Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases
  September 28, 2021

• ORGANIZATION Chuikyo Payer Rep Wants to Cut into Cost-Based Method, Adjustment Rate, Off-Year Revision in FY2022 Reform, Eyes Special Rules for Aducanumab
  September 27, 2021

• BUSINESS Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts
  September 27, 2021

• REGULATORY One-Month Business Suspension Order Likely for Choseido over Generic Recalls
  September 24, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 80
• 81
• 82
• 83
• 84
• 85
• 86
• 87
• 88
• …
• Next ›
• 最終 »